Funded Biotechnology Startups in Netherlands
Across these 50 Netherlands biotech entries (latest round date 2026-06-29: The Protein Brewery, $21M; earliest 2021-12-17: NorthSea Therapeutics, $80M), th…
Across these 50 Netherlands biotech entries (latest round date 2026-06-29: The Protein Brewery, $21M; earliest 2021-12-17: NorthSea Therapeutics, $80M), the largest disclosed round is Merus at $300M (2025-06-03). That $300M figure dwarfs the next-largest disclosed amounts, including Onward at $48M (2026-04-16), Leyden Labs at $45M (2026-06-25), and TargED Biopharmaceuticals at $44M (2022-02-19). Another clear pattern is stage/amount clustering around 2024: multiple Seed/Series A rounds with mid-to-high single-digit million figures appear throughout late 2024 (e.g., Citryll $90M on 2024-12-09; LUMICKS $22M on 2024-10-10; VSPARTICLE $7M on 2024-08-08). By classification, “Series Unknown” appears 23 times and “undisclosed” amounts appear 8 times, while disclosed rounds span from a low of $100K (SkylineDx, 2021-12-21) up to Merus’s $300M.
Most recent rounds
50 of 555 more funded startups
This page shows the 50 most recent rounds (back to Dec 2021). The full 55-company history for this listing is available on a paid plan.
Unlock all 55 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What is the biggest disclosed round in this list, and is it a true outlier versus other disclosed amounts?
Merus’s $300M round (2025-06-03) is the top disclosed amount and an outlier relative to the next-largest disclosed rounds like Onward’s $48M (2026-04-16) and Leyden Labs’s $45M (2026-06-25). The gap is visible because no other disclosed value in the rows reaches the $60M+ range except Salvia BioElectronics at $60M (2025-05-27) and Citryll at $90M (2024-12-09).
How concentrated are the rounds in time—are there noticeable clusters among the 2024/2025 entries?
There is a dense mid-series window across 2024, with multiple rounds closing in successive months: for example, Citryll $90M (2024-12-09), LUMICKS $22M (2024-10-10), and Confocal.nl $5M (2024-10-17) fall within a few months of each other. In 2025, high-disclosed rounds also cluster, including Merus $300M (2025-06-03) alongside Salvia BioElectronics $60M (2025-05-27) and Onward $48M (2026-04-16) in the surrounding period.
Which location appears most often in this dataset, and do any cities repeat across different companies?
Amsterdam is the most frequently listed city, recurring across multiple companies such as Leyden Labs (2026-06-25, $45M), Scinvivo (2025-10-28, undisclosed), LUMICKS (2024-10-10, $22M), and VectorY (2023-11-13, $138M). Other multi-company cities include Eindhoven (e.g., Onward $48M on 2026-04-16 and Salvia BioElectronics $60M on 2025-05-27).
How should the stage mix be interpreted—does “Series Unknown” dominate, and how often are amounts undisclosed?
“Series Unknown” appears 23 times out of 50 rows, so most entries cannot be mapped to a specific labeled stage from the dataset. Separately, amounts are marked “undisclosed” in 8 rows (e.g., Scinvivo 2025-10-28; Hudson River Biotechnology 2024-04-12), which means outlier comparisons should rely only on disclosed amounts.
What’s the range of disclosed round sizes, and where do the smallest disclosed rounds sit?
Disclosed amounts run from $100K (SkylineDx, 2021-12-21) up to $300M (Merus, 2025-06-03). Near the low end are several sub-$1M or near-$1M disclosed rounds such as Bionomic at $380K (2024-11-07) and Intravacc at $630K (2024-01-11), contrasting sharply with the mid-$40M to $60M band seen at Leyden Labs ($45M, 2026-06-25) and Salvia BioElectronics ($60M, 2025-05-27).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.